Literature DB >> 26603737

Validity of standard gamble utilities in patients referred for aortic valve replacement.

Amjad I Hussain1, Andrew M Garratt2, Jan Otto Beitnes3, Lars Gullestad3, Kjell I Pettersen3.   

Abstract

PURPOSE: Standard gamble (SG) is the preferred method of assessing preferences in situations with uncertainty and risk, which makes it relevant to patients considered for aortic valve replacement (AVR). The present study assesses SG preferences in patients with severe aortic stenosis (AS).
METHODS: All patients >18 years old with severe AS referred for AVR to our institution were invited to enroll in the study. The SG was administered by a clinical research nurse. The SF-36, EQ-5D 3L, Hospital Anxiety and Depression Scale (HADS), and AS symptoms were administered by self-completed questionnaire. We hypothesized that SG utilities would have low-to-moderate correlations with physical and mental aspects of health based on our pathophysiological understanding of severe AS. No correlations were expected with echocardiographic measures of the aortic valve.
RESULTS: The response rate for SG was 98 %. SG moderately correlated with physical aspects of SF-36 (PCS, role-physical, vitality), health transition, AS symptoms, and EQ-VAS (ρ S = 0.31-0.39, p < 0.001) and had low correlation with mental aspects of SF-36 and EQ-5D (ρ S = 0.17-0.28, p < 0.001). No correlation was found between SG and HADS, echocardiographic measures, age, gender, or education level (ρ S = 0.01-0.06).
CONCLUSIONS: SG is an acceptable and feasible method of assessing preferences in patients with severe AS that has evidence for validity. The inclusion of uncertainty lends the SG face validity in this population as a direct approach to assessing preferences and basis for QALY calculations.

Entities:  

Keywords:  Aortic valve replacement; Patient preferences; Patient-reported outcomes; Standard gamble; Utility; Validity

Mesh:

Year:  2015        PMID: 26603737     DOI: 10.1007/s11136-015-1186-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  51 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

2.  Short form 36 (SF-36) health survey: normative data from the general Norwegian population.

Authors:  J H Loge; S Kaasa
Journal:  Scand J Soc Med       Date:  1998-12

3.  Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values.

Authors:  P Dolan; M Sutton
Journal:  Soc Sci Med       Date:  1997-05       Impact factor: 4.634

4.  An experimental test of a theoretical foundation for rating-scale valuations.

Authors:  H Bleichrodt; M Johannesson
Journal:  Med Decis Making       Date:  1997 Apr-Jun       Impact factor: 2.583

5.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  Circulation       Date:  2014-03-03       Impact factor: 29.690

Review 6.  Utility approach to measuring health-related quality of life.

Authors:  G W Torrance
Journal:  J Chronic Dis       Date:  1987

7.  Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

Authors:  J H Chesebro; G Knatterud; R Roberts; J Borer; L S Cohen; J Dalen; H T Dodge; C K Francis; D Hillis; P Ludbrook
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

8.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

9.  Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain.

Authors:  Olav Magnus S Fredheim; Petter C Borchgrevink; Turi Saltnes; Stein Kaasa
Journal:  J Pain Symptom Manage       Date:  2007-07-09       Impact factor: 3.612

10.  Methodological issues of patient utility measurement. Experience from two clinical trials.

Authors:  M P Rutten-van Mölken; C H Bakker; E K van Doorslaer; S van der Linden
Journal:  Med Care       Date:  1995-09       Impact factor: 2.983

View more
  3 in total

1.  Patient-centered benefit-risk analysis of transcatheter aortic valve replacement.

Authors:  Kevin Marsh; Natalia Hawken; Ella Brookes; Carrie Kuehn; Barry Liden
Journal:  F1000Res       Date:  2019-04-08

2.  Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision-Making of Aortic Valve Replacement.

Authors:  Amjad I Hussain; Andrew M Garratt; Cathrine Brunborg; Svend Aakhus; Lars Gullestad; Kjell I Pettersen
Journal:  J Am Heart Assoc       Date:  2016-03-18       Impact factor: 5.501

3.  Patient values and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: a systematic review.

Authors:  Lyubov Lytvyn; Gordon H Guyatt; Veena Manja; Reed A Siemieniuk; Yuan Zhang; Thomas Agoritsas; Per O Vandvik
Journal:  BMJ Open       Date:  2016-09-29       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.